CORD-19:f22ac602926d152936dd6af839da45bf8290e038 / 2255-2481 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T18","span":{"begin":0,"end":226},"obj":"Sentence"}],"text":"As the binding affinity of Ang II for the AT 2 receptor does not differ from that for the AT 1 receptor, it is considered that AT 2 -receptor stimulation contributes to the beneficial actions of AT 1 -receptor blockers (ARBs)."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T18","span":{"begin":0,"end":226},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"As the binding affinity of Ang II for the AT 2 receptor does not differ from that for the AT 1 receptor, it is considered that AT 2 -receptor stimulation contributes to the beneficial actions of AT 1 -receptor blockers (ARBs)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T12","span":{"begin":42,"end":44},"obj":"Disease"},{"id":"T13","span":{"begin":90,"end":92},"obj":"Disease"},{"id":"T14","span":{"begin":127,"end":129},"obj":"Disease"},{"id":"T15","span":{"begin":195,"end":197},"obj":"Disease"}],"attributes":[{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0008840"},{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0008840"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0008840"},{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0008840"}],"text":"As the binding affinity of Ang II for the AT 2 receptor does not differ from that for the AT 1 receptor, it is considered that AT 2 -receptor stimulation contributes to the beneficial actions of AT 1 -receptor blockers (ARBs)."}